Difference between revisions of "Part:BBa K4606011"
Line 5: | Line 5: | ||
==Description== | ==Description== | ||
− | + | <html> | |
+ | <p>For detailed design information, you can look up the registry of BBa_K4606007, BBa_K4606002 and BBa_K4606003.</p> | ||
+ | <p>In this part, we integrated the fragment sequence of the SMAD4(WT) gene in front of the luciferase gene and loaded them together into the plasmid vector.</p> | ||
+ | <div style="margin:auto; width: 400px"> | ||
+ | <img src="https://static.igem.wiki/teams/4606/wiki/part-composite-1-smad4-wt-map.jpg" width="400px"> | ||
+ | </div> | ||
+ | <div style="margin:auto; width:400px;"> | ||
+ | <p>Figure 1. Expression map of the composite plasmids of SMAD4-WT.</p> | ||
+ | </div> | ||
+ | <p>This segment of SMAD4(WT) will then be transcribed and expressed together with the luciferase gene in cells. If SMAD4(WT) gene is inhibited by miRNA, its downstream luciferase will not be expressed normally. Therefore, we could analyze whether SMAD4(WT) gene was inhibited by examining the luciferase activity.</p> | ||
+ | <p>Due to the addition of the AmpR gene to the plasmid, we could easily confirm whether the recombination was successful or not, as only the recombinants can grow into colonies on the medium supplemented with Ampicillin.</p> | ||
+ | <div style="margin:auto; width: 400px"> | ||
+ | <img src="https://static.igem.wiki/teams/4606/wiki/part-composite-1-smad4-wt-plasmid.jpg" width="400px"> | ||
+ | </div> | ||
+ | <div style="margin:auto; width:400px;"> | ||
+ | <p>Figure 2. Verification of the recombinant plasmid of SMAD4-WT. | ||
+ | <br>1#: Blank control (ddH2O). | ||
+ | <br>2#: Negative control (empty vector without target gene). | ||
+ | <br>3#: Positive control (GAPDH gene was used as a template). | ||
+ | <br>4#: DNA marker. | ||
+ | <br>5-9#: The recombinant plasmid after transformation. | ||
+ | </p> | ||
+ | </div> | ||
+ | </html> | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 02:32, 19 September 2023
Vector- Luciferase-SMAD4(WT)-AmpR
Description
For detailed design information, you can look up the registry of BBa_K4606007, BBa_K4606002 and BBa_K4606003.
In this part, we integrated the fragment sequence of the SMAD4(WT) gene in front of the luciferase gene and loaded them together into the plasmid vector.
Figure 1. Expression map of the composite plasmids of SMAD4-WT.
This segment of SMAD4(WT) will then be transcribed and expressed together with the luciferase gene in cells. If SMAD4(WT) gene is inhibited by miRNA, its downstream luciferase will not be expressed normally. Therefore, we could analyze whether SMAD4(WT) gene was inhibited by examining the luciferase activity.
Due to the addition of the AmpR gene to the plasmid, we could easily confirm whether the recombination was successful or not, as only the recombinants can grow into colonies on the medium supplemented with Ampicillin.
Figure 2. Verification of the recombinant plasmid of SMAD4-WT.
1#: Blank control (ddH2O).
2#: Negative control (empty vector without target gene).
3#: Positive control (GAPDH gene was used as a template).
4#: DNA marker.
5-9#: The recombinant plasmid after transformation.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]